Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.

British journal of haematology - 1 Nov 2004

Akatsu Hiroyasu, Yamagata Hidehisa, Chen Yusen, Miki Tetsuro, Kamino Kouzin, Takeda Masatoshi, Campbell William, Kondo Ikuko, Kosaka Kenji, Yamamoto Takayuki, Okada Hidechika

Abstract excerpt

Thrombin-activatable fibrinolysis inhibitor (TAFI) was reported as an anaphylatoxin-inactivating enzyme generated by proteolytic cleavage of its zymogen, and is the same enzyme as that first designated by our group as procarboxypeptidase R (proCPR). Its level in plasma appears to influence vascular disease. In addition, TAFI activity is strongly influenced by genetic polymorphism, especially at amino acids 147...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Cadaver

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carboxypeptidase B2

Share to Cerebral Infarction

Share to Intracranial Arteriosclerosis

Share to Nucleic Acid Hybridization

Share to Polymorphism, Genetic

Share to Risk Factors

Source

Identifiers

PMID: 15521922
DOI: 10.1111/j.1365-2141.2004.05219.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.PMID 15521922Read ↗

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.Semantic proximity Read ↗

Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: analysis of a normal Japanese population.Semantic proximity Read ↗

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.Semantic proximity Read ↗

Association between the Thr325Ile polymorphism of the thrombin-activatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study.Semantic proximity Read ↗

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.Semantic proximity Read ↗

Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infarction.Semantic proximity Read ↗

Genetic determinants of plasma factor VII activity in the Japanese.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population.Semantic proximity Read ↗

The alanine/threonine polymorphism of the alpha-1-antichymotrypsin (SERPINA3) gene and ruptured intracranial aneurysms in the Japanese population.Semantic proximity Read ↗

A new functional assay of thrombin activatable fibrinolysis inhibitor.Semantic proximity Read ↗

Protein C deficiency found in a patient with acute myocardial infarction: a single base mutation 157 Arg (CGA) to stop codon (TGA).Semantic proximity Read ↗

Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.